Literature DB >> 8144871

Hirsutism and the effectiveness of spironolactone in its management.

G R McMullen1, A J Van Herle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8144871     DOI： 10.1007/BF03348960

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  63 in total

1.  THE EFFECT OF ANTI-ANDROGENS ON THE RESPONSE OF RAT PREPUTIAL GLANDS TO TESTOSTERONE.

Authors:  E L JONES; L WOODBURY
Journal:  J Invest Dermatol       Date:  1964-09       Impact factor: 8.551

Review 2.  The metabolism and biopharmaceutics of spironolactone in man.

Authors:  H W Overdiek; F W Merkus
Journal:  Rev Drug Metab Drug Interact       Date:  1987

3.  Spironolactone therapy and amenorrhea.

Authors:  J I Levitt
Journal:  JAMA       Date:  1970-03-23       Impact factor: 56.272

4.  Spironolactone therapy for hirsutism in a hyperandrogenic woman.

Authors:  K P Ober; J F Hennessy
Journal:  Ann Intern Med       Date:  1978-11       Impact factor: 25.391

5.  Evidence of a role of adrogens in follicular maturation.

Authors:  J P Louvet; S M Harman; J R Schrieber; G T Ross
Journal:  Endocrinology       Date:  1975-08       Impact factor: 4.736

6.  Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.

Authors:  P Spandri; M Gangemi; G B Nardelli; G Meneghetti; R Grandesso; D De Salvia; G B Ambrosio; O Predebon
Journal:  Clin Exp Obstet Gynecol       Date:  1984       Impact factor: 0.146

7.  Spironolactone in the treatment of hirsutism.

Authors:  M G Chapman; M Katz; M Dowsett; W Hague; S L Jeffcoate; C J Dewhurst
Journal:  Acta Obstet Gynecol Scand       Date:  1986       Impact factor: 3.636

8.  Spironolactone and endocrine dysfunction.

Authors: 
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

9.  Pituitary-ovarian relationships in polycystic ovary syndrome.

Authors:  D T Baird; C S Corker; D W Davidson; W M Hunter; E A Michie; P F Van Look
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

10.  Absence of progestational activity of oral spironolactone.

Authors:  S T Nakajima; J R Brumsted; D H Riddick; M Gibson
Journal:  Fertil Steril       Date:  1989-07       Impact factor: 7.329
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.